Sherbrooke Park Advisers LLC Capricor Therapeutics, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $230 Billion
- Q2 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 10,472 shares of CAPR stock, worth $65,240. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,472Holding current value
$65,240% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
140Shares Held
12.3MCall Options Held
4.99MPut Options Held
5.52M-
Vanguard Group Inc Valley Forge, PA2.31MShares$14.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$10.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$9.14 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$6 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$3.43 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $152M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...